Prot #AN2025H0301: The BURAN Study of Buparlisib (AN2025) In Combination with Paclitaxel Compared to Paclitaxel Alone, in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Project: Research project

Project Details

StatusActive
Effective start/end date8/11/218/11/27

Funding

  • INC Research, LLC ((OE) Prot #AN2025H0301 // (OE) Prot #AN2025H0301)
  • Adlai Nortye USA Inc. ((OE) Prot #AN2025H0301 // (OE) Prot #AN2025H0301)